Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers

Cancer Cell

Volumn 34, Issue 4, 2018, Pages 549-560.e9

  Yuan, Jiao ^a   Hu, Zhongyi ^a   Mahal, Brandon A ^b   Zhao, Sihai D ^c   Kensler, Kevin H ^b,d   Pi, Jingjiang ^e   Hu, Xiaowen ^a   Zhang, Youyou ^a   Wang, Yueying ^a   Jiang, Junjie ^a   Li, Chunsheng ^a   Zhong, Xiaomin ^f   Montone, Kathleen T ^a   Guan, Guoqiang ^a   Tanyi, Janos L ^a   Fan, Yi ^g   Xu, Xiaowei ^a   Morgan, Mark A ^a   Long, Meixiao ^h   Zhang, Yuzhen ^e   Zhang, Rugang ⁱ   Sood, Anil K ^j   Rebbeck, Timothy R ^b,d   Dang, Chi V ^i,k   Zhang, Lin ^a   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^f SUN YAT SEN UNIVERSITY   (China)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

ⁱ WISTAR INSTITUTE   (United States)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

more..

Author keywords

cancer disparities; cancer genetics; cancer genomics

Indexed keywords

PROTEIN P53; PHOSPHATIDYLINOSITOL 3 KINASE;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ALASKA NATIVE; ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CHILD; CHROMOSOMAL INSTABILITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; COPY NUMBER VARIATION; EAST ASIAN; ENDOMETRIUM CARCINOMA; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE STRUCTURE; GENETIC ALGORITHM; GENETIC ANCESTRY; GENETIC VARIABILITY; GENETIC VARIATION; GENOMICS; GENOTYPE; GLIOBLASTOMA; HAPLOTYPE MAP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEREDITY; HUMAN; INVASIVE CARCINOMA; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MUTATION RATE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN MICROARRAY; RENAL CELL CARCINOMA; SOMATIC MUTATION; SQUAMOUS CELL LUNG CARCINOMA; CAUCASIAN; GENETICS; MUTATION; NEOPLASM; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; CHROMOSOMAL INSTABILITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOMICS; HUMANS; MALE; MUTATION; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 85053670706     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2018.08.019     Document Type: Article

References (61)

1. Ademuyiwa, F.O., Tao, Y., Luo, J., Weilbaecher, K., Ma, C.X., Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians. Breast Cancer Res. Treat. 161 (2017), 491–499.
2. Alexandrov, L.B., Jones, P.H., Wedge, D.C., Sale, J.E., Campbell, P.J., Nik-Zainal, S., Stratton, M.R., Clock-like mutational processes in human somatic cells. Nat. Genet. 47 (2015), 1402–1407.
3. Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Borresen-Dale, A.L., et al. Signatures of mutational processes in human cancer. Nature 500 (2013), 415–421.
4. Angeloni, S.V., Martin, M.B., Garcia-Morales, P., Castro-Galache, M.D., Ferragut, J.A., Saceda, M., Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells. J. Endocrinol. 180 (2004), 497–504.
5. Araujo, L.H., Timmers, C., Bell, E.H., Shilo, K., Lammers, P.E., Zhao, W., Natarajan, T.G., Miller, C.J., Zhang, J., Yilmaz, A.S., et al. Genomic characterization of non-small-cell lung cancer in African Americans by targeted massively parallel sequencing. J. Clin. Oncol. 33 (2015), 1966–1973.
6. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57 (1995), 289–300.
7. Beroukhim, R., Mermel, C.H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J.S., Dobson, J., Urashima, M., et al. The landscape of somatic copy-number alteration across human cancers. Nature 463 (2010), 899–905.
8. Bhatia, G., Tandon, A., Patterson, N., Aldrich, M.C., Ambrosone, C.B., Amos, C., Bandera, E.V., Berndt, S.I., Bernstein, L., Blot, W.J., et al. Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture. Am. J. Hum. Genet. 95 (2014), 437–444.
9. Biffi, A., Anderson, C.D., Nalls, M.A., Rahman, R., Sonni, A., Cortellini, L., Rost, N.S., Matarin, M., Hernandez, D.G., Plourde, A., et al. Principal-component analysis for assessment of population stratification in mitochondrial medical genetics. Am. J. Hum. Genet. 86 (2010), 904–917.
10. Borresen-Dale, A.L., TP53 and breast cancer. Hum. Mutat. 21 (2003), 292–300.
11. Burrell, R.A., McClelland, S.E., Endesfelder, D., Groth, P., Weller, M.C., Shaikh, N., Domingo, E., Kanu, N., Dewhurst, S.M., Gronroos, E., et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 494 (2013), 492–496.
12. Campbell, J.D., Lathan, C., Sholl, L., Ducar, M., Vega, M., Sunkavalli, A., Lin, L., Hanna, M., Schubert, L., Thorner, A., et al. Comparison of prevalence and types of mutations in lung cancers among black and white populations. JAMA Oncol. 3 (2017), 801–809.
13. Carter, H., Marty, R., Hofree, M., Gross, A.M., Jensen, J., Fisch, K.M., Wu, X., DeBoever, C., Van Nostrand, E.L., et al. Interaction landscape of inherited polymorphisms with somatic events in cancer. Cancer Discov. 7 (2017), 410–423.
14. Carter, S.L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P.W., Onofrio, R.C., Winckler, W., Weir, B.A., et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30 (2012), 413–421.
15. Carter, S.L., Eklund, A.C., Kohane, I.S., Harris, L.N., Szallasi, Z., A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38 (2006), 1043–1048.
16. Carter, S.L., Meyerson, M., Getz, G., Accurate estimation of homologue-specific DNA concentration-ratios in cancer samples allows long-range haplotyping. Nat. Preced., 2011 http://hdl.handle.net/10101/npre.2011.6494.1.
17. Daly, B., Olopade, O.I., A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J. Clin. 65 (2015), 221–238.
18. Davoli, T., Uno, H., Wooten, E.C., Elledge, S.J., Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science, 355, 2017, 10.1126/science.aaf8399.
19. Deng, J., Chen, H., Zhou, D., Zhang, J., Chen, Y., Liu, Q., Ai, D., Zhu, H., Chu, L., Ren, W., et al. Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations. Nat. Commun., 8, 2017, 1533.
20. DeSantis, C.E., Siegel, R.L., Sauer, A.G., Miller, K.D., Fedewa, S.A., Alcaraz, K.I., Jemal, A., Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J. Clin. 66 (2016), 290–308.
21. Ferrari, S., Cribari-Neto, F., Beta regression for modelling rates and proportions. J. Appl. Stat. 31 (2004), 799–815.
22. Field, A.P., Meta-analysis of correlation coefficients: a Monte Carlo comparison of fixed- and random-effects methods. Psychol. Methods 6 (2001), 161–180.
23. Graffelman, J., Exploring diallelic genetic markers: the HardyWeinberg package. J. Stat. Softw. 64 (2015), 1–23.
24. Gravel, S., Zakharia, F., Moreno-Estrada, A., Byrnes, J.K., Muzzio, M., Rodriguez-Flores, J.L., Kenny, E.E., Gignoux, C.R., Maples, B.K., Guiblet, W., et al. Reconstructing Native American migrations from whole-genome and whole-exome data. PLoS Genet., 9, 2013, e1004023.
25. Guda, K., Veigl, M.L., Varadan, V., Nosrati, A., Ravi, L., Lutterbaugh, J., Beard, L., Willson, J.K., Sedwick, W.D., Wang, Z.J., et al. Novel recurrently mutated genes in African American colon cancers. Proc. Natl. Acad. Sci. USA 112 (2015), 1149–1154.
26. Huang, F.W., Mosquera, J.M., Garofalo, A., Oh, C., Baco, M., Amin-Mansour, A., Rabasha, B., Bahl, S., Mullane, S.A., Robinson, B.D., et al. Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations. Cancer Discov. 7 (2017), 973–983.
27. Huo, D., Hu, H., Rhie, S.K., Gamazon, E.R., Cherniack, A.D., Liu, J., Yoshimatsu, T.F., Pitt, J.J., Hoadley, K.A., Troester, M., et al. Comparison of breast cancer molecular features and survival by African and European ancestry in the cancer Genome Atlas. JAMA Oncol. 3 (2017), 1654–1662.
28. Iorio, F., Knijnenburg, T.A., Vis, D.J., Bignell, G.R., Menden, M.P., Schubert, M., Aben, N., Goncalves, E., Barthorpe, S., Lightfoot, H., et al. A landscape of pharmacogenomic interactions in cancer. Cell 166 (2016), 740–754.
29. Kandoth, C., McLellan, M.D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J.F., Wyczalkowski, M.A., et al. Mutational landscape and significance across 12 major cancer types. Nature 502 (2013), 333–339.
30. Keenan, T., Moy, B., Mroz, E.A., Ross, K., Niemierko, A., Rocco, J.W., Isakoff, S., Ellisen, L.W., Bardia, A., Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrence. J. Clin. Oncol. 33 (2015), 3621–3627.
31. Korn, J.M., Kuruvilla, F.G., McCarroll, S.A., Wysoker, A., Nemesh, J., Cawley, S., Hubbell, E., Veitch, J., Collins, P.J., Darvishi, K., et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 40 (2008), 1253–1260.
32. Krishnan, B., Rose, T.L., Kardos, J., Milowsky, M.I., Kim, W.Y., Intrinsic genomic differences between African American and white patients with clear cell renal cell carcinoma. JAMA Oncol., 2016, 10.1001/jamaoncol.2016.0005.
33. Kytola, V., Topaloglu, U., Miller, L.D., Bitting, R.L., Goodman, M.M., D Agostino, R.B. Jr., Desnoyers, R.J., Albright, C., Yacoub, G., Qasem, S.A., et al. Mutational landscapes of smoking-related cancers in Caucasians and African Americans: precision oncology perspectives at Wake Forest Baptist Comprehensive Cancer Center. Theranostics 7 (2017), 2914–2923.
34. Liu, Y., Nyunoya, T., Leng, S., Belinsky, S.A., Tesfaigzi, Y., Bruse, S., Softwares and methods for estimating genetic ancestry in human populations. Hum. Genomics, 7, 2013, 1.
35. Loo, L.W., Wang, Y., Flynn, E.M., Lund, M.J., Bowles, E.J., Buist, D.S., Liff, J.M., Flagg, E.W., Coates, R.J., Eley, J.W., et al. Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women. Breast Cancer Res. Treat. 127 (2011), 297–308.
36. Mermel, C.H., Schumacher, S.E., Hill, B., Meyerson, M.L., Beroukhim, R., Getz, G., GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol., 12, 2011, R41.
37. Pemberton, T.J., Wang, C., Li, J.Z., Rosenberg, N.A., Inference of unexpected genetic relatedness among individuals in HapMap Phase III. Am. J. Hum. Genet. 87 (2010), 457–464.
38. Petrovics, G., Li, H., Stumpel, T., Tan, S.H., Young, D., Katta, S., Li, Q., Ying, K., Klocke, B., Ravindranath, L., et al. A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men. EBioMedicine 2 (2015), 1957–1964.
39. Powell, I.J., Epidemiology and pathophysiology of prostate cancer in African-American men. J. Urol. 177 (2007), 444–449.
40. Powell, I.J., Dyson, G., Land, S., Ruterbusch, J., Bock, C.H., Lenk, S., Herawi, M., Everson, R., Giroux, C.N., Schwartz, A.G., Bollig-Fischer, A., Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer Epidemiol. Biomarkers Prev. 22 (2013), 891–897.
41. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A., Reich, D., Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38 (2006), 904–909.
42. Pritchard, J.K., Stephens, M., Donnelly, P., Inference of population structure using multilocus genotype data. Genetics 155 (2000), 945–959.
43. Reinhold, K., Engqvist, L., The variability is in the sex chromosomes. Evolution 67 (2013), 3662–3668.
44. Rosenbaum, P.R., Rubin, D.B., The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983), 41–55.
45. Rosenberg, N.A., Standardized subsets of the HGDP-CEPH Human Genome Diversity Cell Line Panel, accounting for atypical and duplicated samples and pairs of close relatives. Ann. Hum. Genet. 70 (2006), 841–847.
46. Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B.S., Swanton, C., DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol., 17, 2016, 31.
47. Royal, C.D., Novembre, J., Fullerton, S.M., Goldstein, D.B., Long, J.C., Bamshad, M.J., Clark, A.G., Inferring genetic ancestry: opportunities, challenges, and implications. Am. J. Hum. Genet. 86 (2010), 661–673.
48. Rubio-Perez, C., Tamborero, D., Schroeder, M.P., Antolin, A.A., Deu-Pons, J., Perez-Llamas, C., Mestres, J., Gonzalez-Perez, A., Lopez-Bigas, N., In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. Cancer Cell 27 (2015), 382–396.
49. Sankararaman, S., Sridhar, S., Kimmel, G., Halperin, E., Estimating local ancestry in admixed populations. Am. J. Hum. Genet. 82 (2008), 290–303.
50. Schumacher, S.E., Shim, B.Y., Corso, G., Ryu, M.H., Kang, Y.K., Roviello, F., Saksena, G., Peng, S., Shivdasani, R.A., Bass, A.J., Beroukhim, R., Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients. PLoS One, 12, 2017, e0176045.
51. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J. Clin. 66 (2016), 7–30.
52. Smithson, M., Verkuilen, J., A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables. Psychol. Methods 11 (2006), 54–71.
53. Spratt, D.E., Chan, T., Waldron, L., Speers, C., Feng, F.Y., Ogunwobi, O.O., Osborne, J.R., Racial/ethnic disparities in genomic sequencing. JAMA Oncol. 2 (2016), 1070–1074.
54. Stouffer, S.A., Suchman, E.A., DeVinney, L.C., Star, S.A., Williams, R.M.J., The American Soldier, Vol. 1, Adjustment during Army Life. 1949, Princeton University Press.
55. Tang, H., Siegmund, D.O., Johnson, N.A., Romieu, I., London, S.J., Joint testing of genotype and ancestry association in admixed families. Genet. Epidemiol. 34 (2010), 783–791.
56. Torre, L.A., Sauer, A.M., Chen, M.S. Jr., Kagawa-Singer, M., Jemal, A., Siegel, R.L., Cancer statistics for Asian Americans, native Hawaiians, and Pacific Islanders, 2016: converging incidence in males and females. CA Cancer J. Clin. 66 (2016), 182–202.
57. Troester, M.A., Herschkowitz, J.I., Oh, D.S., He, X., Hoadley, K.A., Barbier, C.S., Perou, C.M., Gene expression patterns associated with p53 status in breast cancer. BMC Cancer, 6, 2006, 276.
58. van Iterson, M., van Zwet, E.W., Slagboom, P.E., Heijmans, B.T., Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution. bioRxiv, 2016, 10.1186/s13059-016-1131-9.
59. Wang, B.D., Ceniccola, K., Hwang, S., Andrawis, R., Horvath, A., Freedman, J.A., Olender, J., Knapp, S., Ching, T., Garmire, L., et al. Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nat. Commun., 8, 2017, 15921.
60. Zeng, C., Wen, W., Morgans, A.K., Pao, W., Shu, X.O., Zheng, W., Disparities by race, age, and sex in the improvement of survival for major cancers: results from the national cancer institute surveillance, epidemiology, and end results (SEER) program in the United States, 1990 to 2010. JAMA Oncol. 1 (2015), 88–96.
61. Zhang, Y., Kwok-Shing Ng, P., Kucherlapati, M., Chen, F., Liu, Y., Tsang, Y.H., de Velasco, G., Jeong, K.J., Akbani, R., Hadjipanayis, A., et al. A Pan-cancer proteogenomic Atlas of PI3K/AKT/mTOR pathway alterations. Cancer Cell 31 (2017), 820–832 e823.